Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Aptevo Therapeutics Inc. - Common Stock (NQ:APVO)

1.990 +0.610 (+44.20%)
Streaming Delayed Price Updated: 3:46 PM EDT, Apr 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 75,272,749
Open 1.500
Bid (Size) 1.990 (4)
Ask (Size) 2.000 (3)
Prev. Close 1.380
Today's Range 1.477 - 2.640
52wk Range 0.9423 - 180.19
Shares Outstanding 11,523,716
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
On Thursday, there are stocks with unusual volume. Let's take a look.
Join us as we delve into today's session and uncover the stocks that are standing out with unusual volume. 
Via Chartmill
Let's have a look at the top gainers and losers in the middle of the day of today's session.
Looking for insights into the US markets in the middle of the day on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill

Performance

YTD
-56.5%
-56.5%
1 Month
-35.6%
-35.6%
3 Month
-56.5%
-56.5%
6 Month
-66.4%
-66.4%
1 Year
-98.6%
-98.6%

More News

Read More
11 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Aptevo Stock Rises On $2.1M Registered Direct Offering, Warrant Sale: Retail Sentiment Touches Year-High
Via Stocktwits
Topics Government
Exposures Political
Aptevo Therapeutics Interview to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Via ACCESS Newswire
Aptevo Therapeutics Reports 2024 Financial Results And Provides A Business Update
Via ACCESS Newswire
These stocks that are showing activity before the opening bell on Thursday.
Via Chartmill
Aptevo Therapeutics $2.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
Via ACCESS Newswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
100% of Patients Achieve Remission Within 30 Days in Cohort 1 of Bispecific Mipletamig Frontline AML Trial
Via ACCESSWIRE
Bispecific Antibody, APVO442, Differentiated to Treat Prostate Cancer with Precision Tumor Targeting and Reduced Risk of Side Effects
Via ACCESSWIRE
What's Going On With Aptevo Therapeutics Shares Friday?
Via Benzinga
Why Penguin Solutions Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Via Benzinga
Curious about the stocks that are showing activity after the closing bell on Wednesday?
Via Chartmill
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Aptevo Therapeutics Says Two Additional Patients In Early-Stage Leukemia Trial Achieve Remission Within 30 Days of Treatment
Via Benzinga
RAINIER Trial Data Update: Two Additional AML Patients Achieve Remission Within 30 Days of Treatment
Via ACCESS Newswire
Aptevo Highlights APVO603: A Novel Bispecific Antibody Targeting 4-1BB and OX40 for Enhanced Solid Tumor Immunotherapy
Via ACCESS Newswire
Aptevo to Participate in March Conferences
Via ACCESS Newswire
Aptevo's Peter Pavlik, PhD, Chairing Session on "Bi and Multispecific Biologics" at Cambridge Healthcare Institute's Pep Talk 2025
Via ACCESSWIRE
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Aptevo Therapeutics Announces Exercise of Warrants for $6.2 Million Gross Proceeds
Via ACCESSWIRE
Aptevo Therapeutics Announces 1-for 37 Reverse Stock Split As Part of Nasdaq Compliance Plan
Via ACCESSWIRE
Proving the Concept: Aptevo Technology, Pipeline, to Exemplify the Speed and Power of Modular Biotherapeutics at Presentation
Via ACCESSWIRE
Aptevo Highlights the Potential of the Company's Robust Portfolio in Cancer Immunotherapy, the Success of Bispecifics as a Category, and Their Growing Importance in the Oncology Treatment Paradigm
Via ACCESSWIRE

Frequently Asked Questions

Is Aptevo Therapeutics Inc. - Common Stock publicly traded?
Yes, Aptevo Therapeutics Inc. - Common Stock is publicly traded.
What exchange does Aptevo Therapeutics Inc. - Common Stock trade on?
Aptevo Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Aptevo Therapeutics Inc. - Common Stock?
The ticker symbol for Aptevo Therapeutics Inc. - Common Stock is APVO on the Nasdaq Stock Market
What is the current price of Aptevo Therapeutics Inc. - Common Stock?
The current price of Aptevo Therapeutics Inc. - Common Stock is 1.990
When was Aptevo Therapeutics Inc. - Common Stock last traded?
The last trade of Aptevo Therapeutics Inc. - Common Stock was at 04/03/25 03:46 PM ET
What is the market capitalization of Aptevo Therapeutics Inc. - Common Stock?
The market capitalization of Aptevo Therapeutics Inc. - Common Stock is 22.93M
How many shares of Aptevo Therapeutics Inc. - Common Stock are outstanding?
Aptevo Therapeutics Inc. - Common Stock has 23M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.